ShowcasesPricing
  1. US-listed companies
  2. Allogene Therapeutics, Inc.

Allogene Therapeutics, Inc.ALLO

Market cap
$466.13M
P/E ratio
Income statementBalance sheetCash flowOther
Raw aggregated data